| ABD | Actin-binding domain |
| Akt | Protein kinase B |
| AML | Acute myeloid leukemia |
| AMPK | AMP-activated protein kinase |
| APC | Adenomatous polyposis coli |
| AXIN | Axis inhibition protein 1 |
| BCa | Bladder cancer |
| BRCA | Breast cancer |
| CAF | Cancer-associated fibroblast |
| CK1α | Casein kinase 1 alpha |
| CRC | Colorectal cancer |
| DFS | Disease-free survival |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ERK | Extracellular regulated protein kinase |
| ESCC | Esophageal squamous cell carcinoma |
| ECM | Extracellular matrix |
| FAB | Focal adhesion binding |
| FAK | Focal adhesion kinase |
| FZD | Frizzled |
| GAP | GTPase-activating protein |
| GC | Gastric cancer |
| GEF | Guanine nucleotide exchange factor |
| GIST | Gastrointestinal stromal tumor |
| GSK3β | Glycogen synthase kinase 3 beta |
| HCC | Hepatocellular carcinoma |
| HEK | Human embryonic kidney |
| HFF | Human foreskin fibroblast |
| HNSCC | Head and neck squamous cell carcinoma |
| IHC | Immunohistochemistry |
| LEF | Lymphoid enhancer-binding factor |
| LNM | Lymph node metastasis |
| LUAD | Lung adenocarcinoma |
| MET | Hepatocyte growth factor receptor |
| MIBC | Muscle-invasive bladder cancer |
| mTOR | Mechanistic target of rapamycin |
| NSCLC | Non-small-cell lung cancer |
| OS | Overall survival |
| PDAC | Pancreatic ductal adenocarcinoma |
| PFS | Progression free survival |
| PM | Peritoneal metastasis |
| PTB | Phosphotyrosine-binding |
| PTC | Papillary thyroid carcinoma |
| PTP | Protein tyrosine phosphatase |
| RCC | Renal cell carcinoma |
| RFS | Relapse-free survival |
| RhoA | Ras homolog family member A |
| RTK | Receptor tyrosine kinase |
| SAM | Sterile alpha motif |
| SH2 | Src homology 2 |
| TCF | T cell factor |
| TCGA | The Cancer Genome Atlas |
| UALCAN | The University of ALabama at Birmingham CANcer data analysis Portal |
| YAP | Yes-associated protein |